Optimization of prothrombin time measurements in canine plasma

American Journal of Veterinary Research

Volumn 58, Issue 3, 1997, Pages 236-241

  Mischke, Reinhard ^a   Nolte, Ingo ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; COMPARATIVE STUDY; DOG; DOG DISEASE; FEMALE; HUMAN; HYPOPROTHROMBINEMIA; MALE; PROTHROMBIN TIME; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENCE;

ANIMALS; DOG DISEASES; DOGS; FACTOR V DEFICIENCY; FACTOR VII; FACTOR VII DEFICIENCY; FACTOR X DEFICIENCY; FEMALE; HUMANS; HYPOPROTHROMBINEMIAS; MALE; PROTHROMBIN TIME; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

EID: 0031093892     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rogers KS, Barton CL, Benson PA, et al. Effects of single-dose L-asparaginase on coagulation values in healthy dogs and dogs with lymphoma. Am J Vet Res 1992;53:580-584.
2. Millis DL, Hauptman JG, Fulton RB. Abnormal hemostatic profiles and gastric necrosis in canine gastric dilatation-volvulus. Vet Surg 1993;22:93-97.
3. 1 and its epoxide measured in serum of dogs exposed to an anticoagulant. Am J Vet Res 1989;50:1704-1709.
4. Woody BJ, Murphy MJ, Ray AC, et al. Coagulopathic effects and therapy of brodifacoum toxicosis in dogs. J Vet Intern Med 1992; 6:23-28.
5. Schulman A, Lusk R, Lippincott CL, et al. Diphacinone-induced coagulopathy in the dog. J Am Vet Med Assoc 1986;188:402-405.
6. Badylak SF, Van Vleet JF. Alterations of prothrombin time and activated partial thromboplastin time in dogs with hepatic disease. Am J Vet Res 1981;42:2053-2056.
7. Marbet GA, Griffith MJ. Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogs. Thromb Haemost 1986;55:78-85.
8. Hammer AS, Couto CG, Swardson C, et al. Hemostatic abnormalities in dogs with hemangiosarcoma. J Vet Intern Med 1991; 5:11-14.
9. Hargis AM, Feldman BF. Evaluation of hemostatic defects secondary to vascular tumors in dogs: 11 cases (1983-1988). J Am Vet Med Assoc 1991;198:891-894.
10. Mischke R, Nolte I. Labordiagnostik und Differentialdiagnose der Verbrauchskoagulopathie beim Hund. Berl Munch Tierarztl Wochenschr 1992;105:401-410.
11. Lutze G, Kutschmann K. Gerinnungsanalytische Untersuchungen bei klinisch gesunden Hunden. Mh Vet Med 1985;40: 844-846.
12. Zondag ACP, Kolb AM, Bax NMA. Normal values of coagulation in canine blood. Haemostasis 1985;15:318-323.
13. Mischke R. Methodische Aspekte für die koagulometrische Aktivitätsbestimmung der Gerinnungsfaktoren II, V, VII und X aus Hundeplasma. Zentralbl Veterinarmed [A] 1994;41:431-442.
14. Osbaldiston GW, Stowe EC, Griffith PR. Blood coagulation: comparative studies in dogs, cats, horses and cattle. Br Vet J 1970; 126:512-521.
15. Freudiger U. Untersuchungen über die Gerinnungsvalenz am Plasma gesunder und kranker Hunde. Zentralbl Veterinarmed 1954;1:735-744.
16. Nolte I, Heyde P, Mischke R, et al. A study on the efficacy of a phospholipid solution in dogs with aspirin-induced thrombocytopathy. Zentralbl Veterinarmed [A] 1994;41:385-395.
17. Dodds WJ. Hemostasis. In: Kaneko JJ, ed. Clinical biochemistry of domestic animals. San Diego: Academic Press Inc, 1989;274-315.
18. Kazal LA, Amsel S, Miller OP, et al. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Soc Exp Med 1963;113:989-994.
19. Barthels M, Bruhn HD, Duckert F, et al. Bestimmung der Thromboplastinzeit mit einem neuen standardisierten Thromboplastin aus menschlicher Plazenta. Ergebnisse einer kooperativen Studie. J Clin Chem Clin Biochem 1987;25:267-280.
20. Greene CE, Tsang VCW, Prestwood AK, et al. Coagulation studies of plasmas from healthy domesticated animals and persons. Am J Vet Res 1981;42:2170-2177.
21. Loeliger EA, Van Halem-Visser LP. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization. Thromb Haemost 1979;42:1115-1127.
22. Owren PA. Thrombotest: a new method for controlling anticoagulant therapy. Lancet 1959;2:754.
23. Owren PA. Normotest in the evaluation of liver function. In: Hemker HC, Loeliger EA, Veltkamp JJ, eds. Human blood coagulation. Leiden, The Netherlands: University Press, 1970;369-378.
24. Fischer M, Falkensammer Ch. Hepato Quick-ein neues Thromboplastinzeitsystem-im Vergleich zu Normotest und Thrombotest. Wien Klin Wochenschr 1974;86:577-583.
25. Cook AK, Werner LL, O'Neill Sh L, et al. Factor X deficiency in a Jack Russel Terrier. Vet Clin Pathol 1993;22:68-71.
26. Mount ME, Woody BJ, Murphy MJ. The anticoagulant rodenticides. In: Kirk RW, ed. Current veterinary therapy IX. Small animal practice. Philadelphia: WB Saunders Co, 1986;156-165.